• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制TACC3可促进乳腺癌细胞的增殖、侵袭及上皮-间质转化途径。

Inhibiting of TACC3 Promotes Cell Proliferation, Cell Invasion and the EMT Pathway in Breast Cancer.

作者信息

Huo Qin, Chen Siqi, Li Zhenwei, Wang Juan, Li Jiaying, Xie Ni

机构信息

Biobank, Institute of Translational medicine, Shenzhen Second People's Hospital, Graduate School of Guangzhou Medical University, Shenzhen, China.

Department of Clinical Medicine, University of South China, Hengyang, China.

出版信息

Front Genet. 2021 Jun 3;12:640078. doi: 10.3389/fgene.2021.640078. eCollection 2021.

DOI:10.3389/fgene.2021.640078
PMID:34149795
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8209498/
Abstract

Accumulating evidences indicate that transforming acidic coiled-coil 3 (TACC3) is a tumor-related gene, was highly expressed in a variety of human cancers, which is involved in cancer development. However, the potential role of TACC3 in breast cancer remains largely unknown. In the present study, we found that TACC3 was highly-expressed in breast cancer tissues, and its level was positively correlated with the clinical features of breast cancer patients. Specifically, TACC3 expression was significantly associated with the estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) status, nodal status, the scarff-bloom-richardson (SBR) grade, nottingham prognostic index (NPI), age, subtypes, and triple-negative and basal-like status, suggesting that TACC3 may be a potential diagnostic indicator of breast cancer. Furthermore, functional studies have shown that inhibition of TACC3 can significantly promote the cell proliferation and viability of breast cancer cells. Moreover, TACC3 knockdown suppressed the expression of E-cadherin, but increased the expression of N-cadherin, Snail, ZEB1, and TWIST, which indicate that TACC3 may impact the migration of breast cancer cells . Taken together, these findings indicate that TACC3 may serve as a prognostic and therapeutic indicator of breast cancer.

摘要

越来越多的证据表明,转化酸性卷曲螺旋蛋白3(TACC3)是一种肿瘤相关基因,在多种人类癌症中高表达,参与癌症发展。然而,TACC3在乳腺癌中的潜在作用仍 largely未知。在本研究中,我们发现TACC3在乳腺癌组织中高表达,其水平与乳腺癌患者的临床特征呈正相关。具体而言,TACC3表达与雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体2(HER2)状态、淋巴结状态、斯卡夫-布卢姆-理查森(SBR)分级、诺丁汉预后指数(NPI)、年龄、亚型以及三阴性和基底样状态显著相关,提示TACC3可能是乳腺癌的潜在诊断指标。此外,功能研究表明,抑制TACC3可显著促进乳腺癌细胞的增殖和活力。而且,TACC3基因敲低抑制了E-钙黏蛋白的表达,但增加了N-钙黏蛋白、Snail、ZEB1和TWIST的表达,这表明TACC3可能影响乳腺癌细胞的迁移。综上所述,这些发现表明TACC3可能作为乳腺癌的预后和治疗指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/624f/8209498/18e6ee305bdd/fgene-12-640078-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/624f/8209498/517e17e57ae4/fgene-12-640078-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/624f/8209498/c59b922c34fb/fgene-12-640078-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/624f/8209498/59ea086385a1/fgene-12-640078-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/624f/8209498/f8254f97811e/fgene-12-640078-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/624f/8209498/56a91364d6a1/fgene-12-640078-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/624f/8209498/ef5d53da8692/fgene-12-640078-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/624f/8209498/caef206561b8/fgene-12-640078-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/624f/8209498/18e6ee305bdd/fgene-12-640078-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/624f/8209498/517e17e57ae4/fgene-12-640078-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/624f/8209498/c59b922c34fb/fgene-12-640078-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/624f/8209498/59ea086385a1/fgene-12-640078-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/624f/8209498/f8254f97811e/fgene-12-640078-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/624f/8209498/56a91364d6a1/fgene-12-640078-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/624f/8209498/ef5d53da8692/fgene-12-640078-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/624f/8209498/caef206561b8/fgene-12-640078-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/624f/8209498/18e6ee305bdd/fgene-12-640078-g008.jpg

相似文献

1
Inhibiting of TACC3 Promotes Cell Proliferation, Cell Invasion and the EMT Pathway in Breast Cancer.抑制TACC3可促进乳腺癌细胞的增殖、侵袭及上皮-间质转化途径。
Front Genet. 2021 Jun 3;12:640078. doi: 10.3389/fgene.2021.640078. eCollection 2021.
2
Overexpression of HMGB3 and its prognostic value in breast cancer.HMGB3在乳腺癌中的过表达及其预后价值。
Front Oncol. 2022 Dec 22;12:1048921. doi: 10.3389/fonc.2022.1048921. eCollection 2022.
3
Overexpression of TACC3 in Breast Cancer Associates With Poor Prognosis.TACC3在乳腺癌中的过表达与预后不良相关。
Appl Immunohistochem Mol Morphol. 2018 Feb;26(2):113-119. doi: 10.1097/PAI.0000000000000392.
4
TACC3 transcriptionally upregulates E2F1 to promote cell growth and confer sensitivity to cisplatin in bladder cancer.TACC3 通过转录上调 E2F1 促进膀胱癌细胞生长并增加顺铂敏感性。
Cell Death Dis. 2018 Jan 22;9(2):72. doi: 10.1038/s41419-017-0112-6.
5
Cell division cycle proteinising prognostic biomarker of breast cancer.细胞分裂周期蛋白作为乳腺癌的预后生物标志物。
Biosci Rep. 2020 May 29;40(5). doi: 10.1042/BSR20191227.
6
Downregulation of TACC3 inhibits tumor growth and migration in osteosarcoma cells through regulation of the NF-κB signaling pathway.TACC3的下调通过调节NF-κB信号通路抑制骨肉瘤细胞的肿瘤生长和迁移。
Oncol Lett. 2018 May;15(5):6881-6886. doi: 10.3892/ol.2018.8262. Epub 2018 Mar 14.
7
Transforming acidic coiled-coil-containing protein 3 (TACC3) overexpression in hepatocellular carcinomas is associated with "stemness" and epithelial-mesenchymal transition-related marker expression and a poor prognosis.肝细胞癌中含转化酸性卷曲螺旋蛋白3(TACC3)的过表达与“干性”、上皮-间质转化相关标志物表达及预后不良有关。
Tumour Biol. 2016 Jan;37(1):393-403. doi: 10.1007/s13277-015-3810-7. Epub 2015 Jul 29.
8
A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate.一种高效的 TACC3 抑制剂作为新型抗癌候选药物。
Mol Cancer Ther. 2020 Jun;19(6):1243-1254. doi: 10.1158/1535-7163.MCT-19-0957. Epub 2020 Mar 26.
9
Five miRNAs-mediated PIEZO2 downregulation, accompanied with activation of Hedgehog signaling pathway, predicts poor prognosis of breast cancer.五种微小RNA介导的PIEZO2下调,伴随着刺猬信号通路的激活,预示着乳腺癌的预后不良。
Aging (Albany NY). 2019 May 6;11(9):2628-2652. doi: 10.18632/aging.101934.
10
High Expression of Pseudogene PTTG3P Indicates a Poor Prognosis in Human Breast Cancer.假基因PTTG3P的高表达表明人类乳腺癌预后不良。
Mol Ther Oncolytics. 2019 Mar 27;14:15-26. doi: 10.1016/j.omto.2019.03.006. eCollection 2019 Sep 27.

引用本文的文献

1
Knockdown of TACC3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancer.敲低 TACC3 抑制胰腺癌肿瘤细胞增殖并增加化疗敏感性。
Cell Death Dis. 2023 Nov 27;14(11):778. doi: 10.1038/s41419-023-06313-x.
2
Identification of as a Potential Therapeutic Target Involved in Immune Infiltration in Breast Cancer by Integrated Bioinformatical Analysis.通过综合生物信息学分析鉴定作为参与乳腺癌免疫浸润的潜在治疗靶点。
Breast Cancer (Dove Med Press). 2023 Mar 10;15:213-226. doi: 10.2147/BCTT.S400808. eCollection 2023.
3
Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancer.

本文引用的文献

1
SIRT7 Is a Prognostic Biomarker Associated With Immune Infiltration in Luminal Breast Cancer.SIRT7是一种与腔面型乳腺癌免疫浸润相关的预后生物标志物。
Front Oncol. 2020 May 12;10:621. doi: 10.3389/fonc.2020.00621. eCollection 2020.
2
DriverDBv3: a multi-omics database for cancer driver gene research.DriverDBv3:一个用于癌症驱动基因研究的多组学数据库。
Nucleic Acids Res. 2020 Jan 8;48(D1):D863-D870. doi: 10.1093/nar/gkz964.
3
Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype.Notch信号激活作为三阴性乳腺癌亚型的一个特征
基因表达谱分析以发现三阴性乳腺癌早期诊断和治疗的分子特征。
Front Mol Biosci. 2022 Dec 7;9:1049741. doi: 10.3389/fmolb.2022.1049741. eCollection 2022.
4
Integrated Molecular Characterization to Reveal the Association between Kynurenine 3-Monooxygenase Expression and Tumorigenesis in Human Breast Cancers.综合分子特征分析揭示犬尿氨酸3-单加氧酶表达与人乳腺癌肿瘤发生之间的关联
J Pers Med. 2021 Sep 24;11(10):948. doi: 10.3390/jpm11100948.
J Oncol. 2019 Jul 11;2019:8707053. doi: 10.1155/2019/8707053. eCollection 2019.
4
CDC20 associated with cancer metastasis and novel mushroom‑derived CDC20 inhibitors with antimetastatic activity.与癌症转移相关的 CDC20 及新型蘑菇来源的 CDC20 抑制剂及其抗转移活性。
Int J Oncol. 2019 Jun;54(6):2250-2256. doi: 10.3892/ijo.2019.4791. Epub 2019 Apr 18.
5
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.Metascape 为系统水平数据集的分析提供了面向生物学家的资源。
Nat Commun. 2019 Apr 3;10(1):1523. doi: 10.1038/s41467-019-09234-6.
6
EMT Transition States during Tumor Progression and Metastasis.肿瘤进展和转移过程中的 EMT 过渡态。
Trends Cell Biol. 2019 Mar;29(3):212-226. doi: 10.1016/j.tcb.2018.12.001. Epub 2018 Dec 26.
7
CDK5 Functions as a Tumor Promoter in Human Lung Cancer.CDK5在人类肺癌中作为肿瘤促进因子发挥作用。
J Cancer. 2018 Oct 10;9(21):3950-3961. doi: 10.7150/jca.25967. eCollection 2018.
8
Pretreatment TACC3 expression in locally advanced rectal cancer decreases the response to neoadjuvant chemoradiotherapy.局部晚期直肠癌中预处理TACC3表达降低了对新辅助放化疗的反应。
Aging (Albany NY). 2018 Oct 19;10(10):2755-2771. doi: 10.18632/aging.101585.
9
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
10
Elevated Expression of Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) Is Associated With a Poor Prognosis in Osteosarcoma.转化酸性卷曲螺旋蛋白 3(TACC3)的高表达与骨肉瘤的不良预后相关。
Clin Orthop Relat Res. 2018 Sep;476(9):1848-1855. doi: 10.1097/CORR.0000000000000379.